期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Special issue on“Immunotherapy of cancer:future possible therapy for metastatic cancer”
1
作者 Pravin D.Potdar 《Journal of Cancer Metastasis and Treatment》 CAS 2020年第1期480-482,共3页
The global burden of cancer incidence is estimated to be up to 18.1 million people with 9.6 million deaths in 2018.The major cause of death is due to the high toxicity of chemotherapeutic drugs and drug resistance dev... The global burden of cancer incidence is estimated to be up to 18.1 million people with 9.6 million deaths in 2018.The major cause of death is due to the high toxicity of chemotherapeutic drugs and drug resistance developed by cancer cells.Thus,there is an unmet need for appropriate therapy which can kill cancer cell alone and reduce drug resistance.Immunotherapy is an alternative therapy for cancer which mainly boosts the immune response of these patients and kills cancer cells alone with fewer side effects.Since Professor James Allison from M.D.Anderson Cancer Centre,Texas,USA,received the Noble prize for his outstanding contribution to the field of immunotherapy,there has been great excitement in this field.Immunotherapy has become a powerful branch of cancer therapy for the treatment of various types of cancers due to milder side effects than the presently available chemotherapy or radiotherapy.It mainly works by strengthening the host immune responses against tumor cells by supplementation of modified immune system components.There are four different types of immunotherapies:monoclonal antibodies,cancer vaccines,immune checkpoint inhibitors,and Chimeric Antigen Receptor-T cell therapies.Immunotherapy can be given in combination with mild doses of chemotherapy or radiotherapy obtain effective and non-toxic treatment for most cancer patients. 展开更多
关键词 doses ALONE branch
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部